BOUNDLESS BIO, INC.
🏢 View company profile →4Patents
4Active
4Granted
58Portfolio score
Filing activity: Jan 4, 2022 → Mar 24, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11547711B2 | Replication stress pathway agent compositions and methods for treating cancer | Chemistry; Metallurgy | 2 | Active |
| US11642345B2 | Replication stress pathway agent compositions and methods for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US12246017B2 | Replication stress pathway agent compositions and methods for treating cancer | Chemistry; Metallurgy | 0 | Active |
| US11707462B2 | Checkpoint kinase 1 (CHK1) inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.